{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:13:21Z","timestamp":1788786801685,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016765","name":"Jounce Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ijrobp.2020.04.014","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T22:07:03Z","timestamp":1587161223000},"page":"662-671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Dose and Volume De-Escalation for Human Papillomavirus\u2013Positive Oropharyngeal Cancer is Associated with Favorable Posttreatment Functional Outcomes"],"prefix":"10.1016","volume":"107","author":[{"given":"Corey C.","family":"Foster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanguy Y.","family":"Seiwert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"MacCracken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Melotek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Portugal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Brisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Gooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Spiotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Everett E.","family":"Vokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Haraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2020.04.014_bib1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib2","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1200\/JCO.2013.53.5633","article-title":"Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522","volume":"32","author":"Ang","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib3","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1002\/cncr.27631","article-title":"Late dysphagia after radiotherapy-based treatment of head and neck cancer","volume":"188","author":"Hutcheson","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib4","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ijrobp.2012.08.030","article-title":"Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: Prospective study of patient-reported, observer-rated, and objective outcomes","volume":"85","author":"Hunter","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib5","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ijrobp.2009.05.018","article-title":"Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer","volume":"77","author":"Diaz","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejca.2017.03.006","article-title":"Quality of life in survivors of oropharyngeal cancer: A systematic review and meta-analysis of 1366 patients","volume":"78","author":"H\u00f8xbroe","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib7","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/hed.24879","article-title":"Symptom burden as a driver of decisional regret in long-term oropharyngeal carcinoma survivors","volume":"39","author":"Goepfert","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib8","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/cncr.29207","article-title":"Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer","volume":"121","author":"Xu","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/bjc.2013.458","article-title":"Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy","volume":"109","author":"Langius","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib10","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/lary.27791","article-title":"Chronic opioid use in patients undergoing treatment for oropharyngeal cancer","volume":"129","author":"Silver","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1200\/EDBK_208563","article-title":"Pain management in the era the opioid crisis","volume":"38","author":"Bruera","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): A randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib14","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1200\/JCO.19.01007","article-title":"Phase II trial of de-intensified chemoradiotherapy for human papillomavirus-associated oropharyngeal squamous cell carcinoma","volume":"37","author":"Chera","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib15","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.19.00463","article-title":"Phase II evaluation of aggressive dose de-escalation for adjuvant chemoradiotherapy in human papillomavirus-associated oropharynx squamous cell carcinoma","volume":"37","author":"Ma","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1200\/JCO.2016.68.3300","article-title":"E1308: Phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx- ECOG-ACRIN Cancer Research Group","volume":"35","author":"Marur","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1470-2045(17)30246-2","article-title":"Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: A single-arm, phase 2 study","volume":"18","author":"Chen","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/annonc\/mdy522","article-title":"OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer","volume":"30","author":"Seiwert","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","article-title":"Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs\u00a0Laryngeal Cancer Study Group","volume":"324","author":"Wolf","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnci\/djn460","article-title":"Phase III randomized trial on larynx preservation comparing sequential vs. alternating chemotherapy and radiotherapy","volume":"101","author":"Lefebvre","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib21","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/annonc\/mdw051","article-title":"Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer","volume":"27","author":"Villaflor","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1044\/1058-0360.0302.54","article-title":"A database information storage and reporting system for videofluorographic oropharyngeal motility (OPM) swallowing evaluations","volume":"3","author":"Karnell","year":"1994","journal-title":"Am J Speech Lang Pathol"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00417897","article-title":"A penetration-aspiration scale","volume":"11","author":"Rosenbek","year":"1996","journal-title":"Dysphagia"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib25","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3109\/0284186X.2012.744466","article-title":"The incidence of trismus and long-term impact on health-related quality of life in patients with head and neck cancer","volume":"52","author":"Pauli","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib26","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>3.0.CO;2-S","article-title":"The Performance Status Scale for Head and Neck Cancer Patients and the functional assessment of Cancer Therapy-Head and Neck Scale: A study of utility and validity","volume":"77","author":"List","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ijrobp.2017.10.045","article-title":"Functional outcomes after de-escalated chemoradiation therapy for human papillomavirus-positive oropharyngeal cancer: secondary analysis of a phase 2 trial","volume":"100","author":"Hegde","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cncr.29022","article-title":"A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy","volume":"121","author":"Setton","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijrobp.2016.04.030","article-title":"Final results of a randomized phase 2 trial investigating the addition of cetuximab to induction chemotherapy and accelerated or hyperfractionated chemoradiation for locoregionally advanced head and neck cancer","volume":"9","author":"Seiwert","year":"2016","journal-title":"Int J Radiat Biol Oncol Phys"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib30","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1200\/JCO.2004.12.012","article-title":"Preliminary results of Radiation Therapy Oncology Group 97-03: A randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck","volume":"22","author":"Garden","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib31","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/archotol.134.10.1060","article-title":"Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer","volume":"134","author":"Salama","year":"2008","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/lary.20716","article-title":"Chemoradiation for patients with advanced oral cavity cancer","volume":"120","author":"Stenson","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijrobp.2011.06.1954","article-title":"\u201cPharyngocise\u201d: Randomized controlled trial of preventive exercises to maintain muscle structure and swallowing function during head-and-neck chemoradiotherapy","volume":"83","author":"Carnaby-Mann","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1200\/JCO.18.00896","article-title":"Effect of pregabalin on radiotherapy-related neuropathic pain in patients with head and neck cancer: A randomized controlled trial","volume":"37","author":"Jiang","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.04.014_bib35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.radonc.2013.12.007","article-title":"Dose to the inferior pharyngeal constrictor predicts prolonged gastrostomy tube dependence with concurrent intensity-modulated radiation therapy and chemotherapy for locally advanced head and neck cancer","volume":"110","author":"Vlacich","year":"2014","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620310324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620310324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:46:56Z","timestamp":1759744016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301620310324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0360301620310324"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.04.014","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose and Volume De-Escalation for Human Papillomavirus\u2013Positive Oropharyngeal Cancer is Associated with Favorable Posttreatment Functional Outcomes","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}